Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 12.85
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals in Taiwan. It develops non-silicon-based MEMS by using LIGA technology that could be applied in the manufacture and development of miniaturized devices and micron-scale parts. The company also offers Pocket Air, an inhalation devices for the treatment of respiratory diseases; and PharMatrix, a...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'che
Data is available to registered users only
Buy
Sell